Walgreens Boots Alliance will sell its pharmaceutical wholesale business to AmerisourceBergen in $6.5 billion cash and stock deal.
By TOM MURPHY Walgreens Boots Alliance will sell its pharmaceutical wholesale business to AmerisourceBergen in $6.5 billion cash and stock deal. Pharmaceutical wholesalers essentially act as middlemen, purchasing drugs from manufacturers and then distributing them to customers like drugstore chains.
